A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

420

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY2944876

Administered SC

DRUG

Exenatide extended-release

Administered SC

DRUG

Placebo

Administered SC

DRUG

Metformin

Oral

Trial Locations (51)

11527

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ampelokipoi

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Athens

16602

Blair Medical Associates, Inc., Altoona

27265

High Point Clinical Trials Center, High Point

31238

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chihuahua City

32765

Compass Research, Oviedo

33135

Suncoast Research Group, LLC, Miami

33316

M & O Clinical Research, LLC, Fort Lauderdale

33880

Clinical Research of Central Florida, Winter Haven

34208

Meridien Research, Bradenton

34652

Suncoast Clinical Research, New Port Richey

44690

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Guadalajara

50314

Iderc, P.L.C., Des Moines

57010

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Thessaloniki

58103

Lillestol Research LLC, Fargo

63090

Mercy Health Research, Washington

63141

St John's Mercy Medical Center, St Louis

65807

Mercy Medical Research Institute, Springfield

66606

Cotton O'Neil Diabetes and Endocrinology Center, Topeka

75230

Dallas Diabetes Endocrine Center, Dallas

77478

Southwest Health Associates, P.A., Sugar Land

78218

Oakwell Clinical Research, San Antonio

78626

San Gabriel Clinical Research, Georgetown

78731

Texas Diabetes and Endocrinology, Austin

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

84010

Wade Family Medicine, Bountiful

89000

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tampico

90057

National Research Institute, Los Angeles

91978

Encompass Clinical Research, Spring Valley

92103

Artemis Institute for Clinical Research, San Diego

92262

Desert Medical Group Inc, Palm Springs

93720

Valley Endocrine, Fresno, Fresno

94520

John Muir Physician Network Clinical Research Center, Concord

96813

University of Hawaii, Honolulu

96814

East West Medical Institute, Honolulu

97330

The Corvallis Clinic P.C., Corvallis

100342

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Ploieşti

300456

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Timișoara

400349

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Cluj-Napoca

540098

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Târgu Mureş

700547

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Iași

03063

Southern New Hampshire Diabetes and Endocrinology, Nashua

15-351

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Bialystok

80-546

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gdansk

81-553

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Gdynia

90-242

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Lodz

61-853

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Poznan

70-506

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Szczecin

01-518

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Warsaw

00674

Manati Medical Center, Manatí

00917-3104

American Telemedicine Center, San Juan

All Listed Sponsors
lead

OPKO Health, Inc.

INDUSTRY

NCT02119819 - A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes | Biotech Hunter | Biotech Hunter